Fil Randazzo is currently Founder and CEO Leverage Science. Leverage Science helps funders, investors and innovators identify big ideas and turn them to reality. He is a Senior Advisor at the Institute on Ethics & Policy for Innovation (IEPI).

Previously, Fil served as a Deputy Director at the Bill & Melinda Gates Foundation (BMGF). During his 12.5-year tenure at BMGF, he actively participated in its rapid growth from a small startup to a 1500 employee institution and was part of a management team that oversaw >$2B in investments. Fil co-launched and co-managed the Grand Challenges in Global Health Initiative, which in 2005 established the standard on how BMGF sources, funds and manages innovation. Fil directly managed a $600M investment portfolio which spanned areas such as health, agriculture, education, and policy. His portfolio included some of BMGF’s biggest success stories including Wolbachia based dengue prevention.

From 1994-2004, Fil served a variety of scientific roles at the Chiron Corporation in Emeryville, CA. He earned a Ph.D. in Molecular, Cellular and Development Biology at Indiana University, Bloomington and B.S. in Microbiology and Anthropology from the University of Notre Dame.